Randomized, double-blind, placebo-controlled trial of the oral interleukin-12/23 inhibitor apilimod mesylate for treatment of active Crohn's disease (Q45841458)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Randomized, double-blind, placebo-controlled trial of the oral interleukin-12/23 inhibitor apilimod mesylate for treatment of active Crohn's disease |
scientific article |
Statements
1 reference
Randomized, double-blind, placebo-controlled trial of the oral interleukin-12/23 inhibitor apilimod mesylate for treatment of active Crohn's disease (English)
1 reference
1 reference
Bruce E Sands
1 reference
Eric W Jacobson
1 reference
Thomas Sylwestrowicz
1 reference
Ziad Younes
1 reference
Gerald Dryden
1 reference
Susan Greenbloom
1 reference
1 July 2010
1 reference
16
1 reference
7
1 reference
1209-1218
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference